Mobile

News Massive Bio Has Onboarded Over 120,000 Cancer Patients To Find Their Clinical Trial

Mantle Cell Lymphoma Clinical Trial Opportunities

If you have refractory or relapsed mantle cell lymphoma (MCL), joining a clinical trial may be your best choice.

Compliant with

    Find Your Treatment Now

    A Patient Relations Coordinator will reach out to you soon.

    Your personal data is fully confidential and 100% secure

    You can receive a guidebook with information about lymphoma by filling out the form.

      Find Your Treatment Now

      A Patient Relations Coordinator will reach out to you soon.

      Your personal data is fully confidential and 100% secure

      You can receive a guidebook with information about lymphoma by filling out the form.

      Discover Innovative Mantle Cell Lymphoma Treatments

      Looking for a mantle cell lymphoma treatment can be difficult. Massive Bio’s advanced artificial intelligence (AI) platform can assist you in this long process for free! We will recommend treatment options in MLC clinical trials that match your conditions and clinical characteristics specifically. Once you submit your medical condition information, our oncology informatics experts will review your MCL case and contact you for eligibility.

      Understanding your full range of options for an improved quality of life is crucial when facing a refractory or relapsed mantle cell lymphoma diagnosis. This is particularly true after receiving chemotherapy and targeted therapies like anti-CD20 or BTKi . Our cutting-edge clinical trials for early or advanced stages of lymphoma aim to explore new, targeted treatments designed specifically for patients like you – for free.

      We are pleased to offer you the chance to participate in a new therapy for Mantle Cell Lymphoma, a type of non-Hodgkin’s lymphoma. This therapy for b-cell malignancies has shown encouraging results and may significantly benefit your treatment plan.

      By signing up for this blood cancer trial matching program, you’ll be provided with a personalized treatment option specifically tailored to your medical needs.

      When you register for our matching service, we’ll help you find clinical trials for free that are a good fit for your situation. Here’s how it works:

      Diagnosis: If you have been diagnosed with Mantle Cell Lymphoma that continue to progress in spite of treatment or that has come back and spread to other parts of the body, you might now have a new option in finding a potential clinical trial.

      Innovative Therapy: Our advanced therapy brings together the latest developments in medical science and technology to accurately and effectively treat your disease.

      Personalized Match: We understand that every patient is unique, which is why we tailor treatment plans to align with your specific requirements and medical history, whether you’re dealing with mantle cell lymphoma that has spread to the lymphatic system of the body or has relapsed.

      Expert Guidance: Throughout your journey, even with a relapsed or refractory MCL, our experienced team of medical professionals will be by your side. We will be providing guidance, support, and answering any questions you may have.

      1st Line Anti-CD20 and 1st Line BTKi Therapy: If you have been diagnosed with MCL, it is possible that you have received 1st line anti-CD20 therapy and first line BTKi therapy as part of your treatment regimen. Anti-CD20 antibodies such us rituximab, target a protein called CD20 on the surface of cancerous cells, helping to destroy them. BTK inhibitors such as Acalabrutinib, zanubrutinib, or ibrutinib work by blocking a protein called Bruton’s tyrosine kinase (BTK), which plays a role in the growth and survival of lymphoma cells. If these medications haven’t been effective for you, it suggests that your condition is either refractory or has relapsed. This makes you a potential candidate for participation in this trial.

       

      What is Mantle Cell Lymphoma?

      Mantle cell lymphoma (MCL) is a relatively rare form of non-Hodgkin lymphoma, representing about 6% of non-Hodgkin lymphoma cases. The life expectancy and survival rates for patients with MCL can vary widely, influenced by factors such as the stage of the disease, overall health, age, and response to treatment.

      The median life expectancy for mantle cell lymphoma is often reported to be around 5 to 7 years. However, it’s crucial to note that this is a median, meaning that many patients can live significantly longer, particularly those who are otherwise healthy and respond well to treatment to Car-T Cell therapies . The survival rate for MCL is a statistical measure based on larger population groups and does not necessarily predict the outcome for an individual patient. Some patients might live much longer than these median estimates, while others might have a shorter survival time.

      By signing up for our matching program, you’re taking an active role in exploring new possibilities and gaining access to an innovative therapy that can potentially transform your life. Don’t miss out on this opportunity to enhance your Mantle Cell Lymphoma treatment.

      Join us today and let’s embark on this extraordinary path towards improved health together!

      Why Massive Bio?
      Our AI matching tool makes cancer treatment simple.

      We combine the power of technology with our dedicated team of medical providers to find you the best treatment options available.

      Access the free matching tool

      How Massive Bio Helps Mantle Cell Lymphoma Patients

      Massive Bio offers a quick, easy, and FREE way to find clinical trials for patients like you. With our unique clinical trial matching system and compassionate team, Massive Bio can rapidly match you to MCL clinical trials of new therapies for mantle cell lymphoma. If you aren’t sure what form of mantle cell lymphoma you have, that’s okay. Additional testing can help determine your exact diagnosis.

       

      People's stories
      Star Star Star Star Star

      ““

      Google Reviews
      You are in good hands

      Talk to us. Our nurses and patient relations coordinators are here and happy to help you. You are not alone in this fight.

      Call +1 844 627 7246
      Cancer Clinical Trials Patients Cancer Clinical Trials Patients

      What is a Mantle Cell Lymphoma clinical trial?

      Clinical trials test the latest scientific advancements in Mantle Cell Lymphoma treatment. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. Mantle Cell Lymphoma patients might gain access to promising drugs and innovative treatments long before they're made available to the public.

      Cancer Ribbon

      You are not alone

      You can have an experienced team with you

      Dr. Arturo explains:
      What Are Clinical Trials?

      Cancer is an unfortunate reality that touches most of us at some point in our lives. If you or a loved one has cancer, you may have heard or read that clinical trials could offer access to innovative new treatments. But what exactly is a clinical trial? In this video, Massive Bio co-founder Arturo Loaiza-Bonilla, MD, explains how clinical trials work, what to expect if you enroll in one, and why a clinical trial can be an important treatment option for many cancer patients.

      We dream of the day when cancer disappears from our lives. Massive Bio is working tirelessly on achieving that goal.

      F.A.Q.
      • Why should I trust Massive Bio?

        Why should I trust Massive Bio?

        Massive Bio has provided health to more than 120,000 cancer patients in 25 countries across three continents. It collaborates with over 80 global partners. In 2022, Massive Bio became part of the Precision Cancer Consortium (PCC), alongside major companies such as AstraZeneca, Bayer, Eli Lilly & Company, GSK, Johnson & Johnson/Janssen, Novartis and Roche.

      • What is the process?

        What is the process?

        To find the best clinical research studies for you, we need your medical history and consent. You can provide this consent by filling out the form on this page and the following pages. Once you’ve done that, our patient relations coordinator will contact you to discuss the details and provide further information for clinical research matching report.

      • Why do I have to provide my medical records to enroll in a clinical trial?

        Why do I have to provide my medical records to enroll in a clinical trial?

        To enroll in clinical trial, you must meet highly specific criteria that’s established by the researchers who are conducting the investigation. That includes detailed information about type of cancer, treatment history, response to treatment, and other data that is collected in medical records.

      • What should I do if I don’t have my medical records?

        What should I do if I don’t have my medical records?

        If you are being treated for cancer or any other disease, your doctor should have a complete record of your medical care, including specific information about what form of the disease you have and what treatments you have received. Your patient relations coordinator will contact you and inform you about the details.

      • What are the costs associated with Massive Bio’s services?

        What are the costs associated with Massive Bio’s services?

        Massive Bio provides its services to the patients and their doctors at no cost—you won’t have to pay anything to receive a clinical-research matching report. There are no hidden costs involved.

      • How does Massive Bio protect my personal information?

        How does Massive Bio protect my personal information?

        Massive Bio strictly adheres to all HIPAA guidelines and international regulations focused on maintaining your privacy. We take extra measures to secure your personal information, ensuring it is protected beyond the mandatory requirements.

      • Where can I find clinical research studies in my area?

        Where can I find clinical research studies in my area?

        Your doctor may know of a clinical research study being conducted in your area that’s recruiting participants and is right for you. However, Massive Bio uses its artificial intelligence-powered platform to match patients to clinical research studies of treatments that give you the best chance of a positive outcome and are being conducted in a geographical location that makes sense for you.

      • Can I continue seeing my doctor or oncologist while also taking services of Massive Bio?

        Can I continue seeing my doctor or oncologist while also taking services of Massive Bio?

        Yes, Massive Bio keeps your doctor up to date on your status throughout your participation.